Conjugating Prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapy

AIM: To engineer a novel nanoimmunotherapy comprising Prussian blue nanoparticles (PBNPs) conjugated to antigen-specific cytotoxic T lymphocytes (CTL), which leverages PBNPs for their photothermal therapy (PTT) capabilities and Epstein–Barr virus (EBV) antigen-specific CTL for their ability to traff...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Nanomedicine (Lond)
Autori principali: Burga, Rachel A, Patel, Shabnum, Bollard, Catherine M, Y Cruz, Conrad Russell, Fernandes, Rohan
Natura: Artigo
Lingua:Inglês
Pubblicazione: Future Medicine Ltd 2016
Soggetti:
Preliminary Communication
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4941545/
https://ncbi.nlm.nih.gov/pubmed/27389189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nnm-2016-0160
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi